Ken Bate
Chairman presso ASTRIA THERAPEUTICS, INC.
Patrimonio netto: 319 914 $ in data 31/03/2024
Profilo
Kenneth M.
Bate is the founder of JSB-Partners LP, which was founded in 1999.
He is currently the Chairman of Genocea Biosciences, Inc. since 2018, Chairman of Astria Therapeutics, Inc. since 2019, and Independent Director of Madrigal Pharmaceuticals, Inc. since 2016.
Previously, he served as President, Chief Executive Officer & Director of NitroMed, Inc. from 2007 to 2009, President, Chief Executive Officer & Director of Archemix Corp.
from 2011 to 2012, Chief Executive Officer of MPM BioImpact, Inc. from 1997 to 1999, Lead Independent Director of Cubist Pharmaceuticals LLC from 2015 to 2016, Independent Non-Executive Director of BioMarin Pharmaceutical, Inc. from 2014 to 2017, Director of Coley Pharmaceutical Group, Inc. from 2005 to 2008, Independent Director of Vanda Pharmaceuticals, Inc. from 2015 to 2018, Director of TransMedics, Inc. from 2012 to 2017, and Lead Independent Director of AVEO Pharmaceuticals, Inc. since 2007.
He also served as an Independent Director of Epizyme, Inc. from 2014 to 2022.
Mr. Bate's education includes an undergraduate degree from Williams College and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/04/2024 | 1 198 ( 0.01% ) | 319 914 $ | 31/03/2024 | |
| 02/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Ken Bate
| Società | Posizione | Inizio |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Chairman | 01/02/2016 |
| GENOCEA BIOSCIENCES, INC. | Chairman | 01/12/2018 |
| MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 22/07/2016 |
Precedenti posizioni note di Ken Bate
| Società | Posizione | Fine |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Chairman | 19/01/2023 |
| EPIZYME, INC. | Director/Board Member | 12/08/2022 |
| VANDA PHARMACEUTICALS INC. | Director/Board Member | 13/06/2018 |
| BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 01/01/2017 |
TransMedics, Inc.
 TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Director/Board Member | 01/01/2017 |
Formazione di Ken Bate
| Williams College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BIOGEN INC. | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
JSB-Partners LP
 JSB-Partners LP Investment Banks/BrokersFinance JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA. | Finance |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
TransMedics, Inc.
TransMedics, Inc. Medical SpecialtiesHealth Technology TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Ken Bate
